QIAGEN N.V.
QGEN
$44.20
$0.811.87%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 535.04M | 492.32M | 540.42M | 532.58M | 533.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 535.04M | 492.32M | 540.42M | 532.58M | 533.54M |
| Cost of Revenue | 181.97M | 168.83M | 173.92M | 187.78M | 185.95M |
| Gross Profit | 353.07M | 323.49M | 366.51M | 344.80M | 347.59M |
| SG&A Expenses | 146.77M | 142.39M | 153.88M | 143.11M | 148.75M |
| Depreciation & Amortization | 15.02M | 15.59M | 17.19M | 15.65M | 15.12M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 394.19M | 375.07M | 392.22M | 395.29M | 397.57M |
| Operating Income | 140.85M | 117.26M | 148.21M | 137.29M | 135.97M |
| Income Before Tax | 132.11M | 85.83M | 109.17M | 134.73M | 126.82M |
| Income Tax Expenses | 28.70M | 17.79M | 1.34M | 4.68M | 30.57M |
| Earnings from Continuing Operations | 103.40M | 68.04M | 107.83M | 130.04M | 96.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 103.40M | 68.04M | 107.83M | 130.04M | 96.25M |
| EBIT | 140.85M | 117.26M | 148.21M | 137.29M | 135.97M |
| EBITDA | 191.41M | 168.47M | 179.60M | 188.26M | 185.45M |
| EPS Basic | 0.50 | 0.33 | 0.52 | 0.63 | 0.44 |
| Normalized Basic EPS | 0.42 | 0.36 | 0.48 | 0.43 | 0.41 |
| EPS Diluted | 0.50 | 0.33 | 0.52 | 0.63 | 0.44 |
| Normalized Diluted EPS | 0.42 | 0.35 | 0.48 | 0.43 | 0.40 |
| Average Basic Shares Outstanding | 206.35M | 207.01M | 207.76M | 206.03M | 216.70M |
| Average Diluted Shares Outstanding | 207.83M | 208.94M | 207.76M | 207.53M | 218.18M |
| Dividend Per Share | 0.00 | 0.35 | 0.00 | 0.00 | 0.00 |
| Payout Ratio | -- | -- | -- | 41.71% | -- |